CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-04 | Stark David Matthew Exec. VP Chief Legal Officer | Sale | −13,930 | $10.57 | $147K | 2,974.39 |
| 2021-03-04 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise · Restricted Share Units | −13,930 | 27,861 | ||
| 2021-03-04 | Schultz Kare President and CEO | Option exercise | +59,701 | 860,582 | ||
| 2021-03-04 | Schultz Kare President and CEO | Option exercise · Restricted Share Units | −59,701 | 119,403 | ||
| 2021-03-04 | Sabag Mark See "Remarks" below | Option exercise | +15,920 | 147,842 | ||
| 2021-03-04 | Sabag Mark See "Remarks" below | Option exercise · Restricted Share Units | −15,920 | 31,841 | ||
| 2021-03-04 | O'Grady Brendan P. EVP, North America Commercial | Sale | −703 | $10.80 | $8K | 14,868.49 |
| 2021-03-04 | O'Grady Brendan P. EVP, North America Commercial | Option exercise | +18,905 | 33,773.49 | ||
| 2021-03-04 | O'Grady Brendan P. EVP, North America Commercial | Sale | −7,469 | $10.57 | $79K | 26,304.49 |
| 2021-03-04 | O'Grady Brendan P. EVP, North America Commercial | Option exercise · Restricted Share Units | −18,905 | 37,811 | ||
| 2021-03-04 | Nazzi Gianfranco EVP, International Markets | Grant or award | +12,935 | 12,935 | ||
| 2021-03-04 | Nazzi Gianfranco EVP, International Markets | Sale | −12,935 | $10.58 | $137K | 0 |
| 2021-03-04 | Nazzi Gianfranco EVP, International Markets | Option exercise · Restricted Share Units | −12,935 | 25,870 | ||
| 2021-03-04 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise | +18,905 | 82,968.51 | ||
| 2021-03-04 | Fridriksdottir Hafrun Executive VP, Global R&D | Sale | −9,515 | $10.57 | $101K | 73,453.51 |
| 2021-03-04 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise · Restricted Share Units | −18,905 | 37,811 | ||
| 2021-03-04 | Drape Eric Executive VP Global Operations | Option exercise | +11,940 | 61,231 | ||
| 2021-03-04 | Drape Eric Executive VP Global Operations | Sale | −6,183 | $10.58 | $65K | 55,048 |
| 2021-03-04 | Drape Eric Executive VP Global Operations | Option exercise · Restricted Share Units | −11,940 | 23,880 | ||
| 2021-03-04 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise | +13,930 | 83,987.7 |
Page 47 of 76 · 1,517 trades